Clinical efficacy and safety of icaritin in patients with hepatocellular carcinoma: a real-world study
Icaritin-based therapy has certain efficacy and a favorable safety in uHCC, suggesting a therapeutic alternative for uHCC patients ineligible for standard treatments.
Authors
- Kunyuan Wang
- Yi Lei
- DingLi Liu
- Huaiyu Chen
- Wenxuan Yu (ORCID: https://orcid.org/0000-0002-0132-6905)
- Jingchang He
- Shuai Kang
- Lanlan Zhuang
- Yuchen Lu
- Biao Wang
- Yang Cheng
- Yun Zhu
Institutions
- Nanfang Hospital (CN)
- Guangzhou Women and Children Medical Center (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fphar.2026.1677794
- Primary Topic
- Medicinal Plant Pharmacodynamics Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Southern Medical University
- Nanfang Hospital
- Basic and Applied Basic Research Foundation of Guangdong Province